Timing of Complete Multivessel Revascularization in Patients Presenting With Non-ST-Segment Elevation Acute Coronary Syndrome
Open Access
- 25 March 2024
- journal article
- research article
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 17 (6) , 771-782
Abstract
No abstract availableKeywords
Funding Information
- BIOTRONIK SE und Co KG
This publication has 25 references indexed in Scilit:
- Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trialThe Lancet, 2023
- Culprit Lesion Detection in Patients Presenting With Non-ST Elevation Acute Coronary Syndrome and Multivessel DiseaseCardiovascular Revascularization Medicine, 2022
- Percutaneous complete revascularization strategies using sirolimus-eluting biodegradable polymer-coated stents in patients presenting with acute coronary syndrome and multivessel disease: Rationale and design of the BIOVASC trialAmerican Heart Journal, 2020
- Complete Versus Culprit-Only Lesion Intervention in Patients With Acute Coronary SyndromesJACC, 2018
- Optimal timing of an invasive strategy in patients with non-ST-elevation acute coronary syndrome: a meta-analysis of randomised trialsThe Lancet, 2017
- Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre studyThe Lancet, 2016
- A SMILE and a FrownJACC, 2016
- Single-Staged Compared With Multi-Staged PCI in Multivessel NSTEMI PatientsJACC, 2016
- Long-Term Outcome of a Routine Versus Selective Invasive Strategy in Patients With Non–ST-Segment Elevation Acute Coronary SyndromeJACC, 2010
- Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarctionAmerican Heart Journal, 2004